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Abstract: β-Glucan and black tea are fermented by the colonic microbiota producing short chain
fatty acids (SCFA) and phenolic acids (PA). We hypothesized that the addition of β-glucan, a dietary
fiber, and tea polyphenols to a food matrix like bread will also affect starch digestion in the upper
gut and thus further influence colonic fermentation and SCFA production. This study investigated
SCFA and PA production from locally developed breads: white bread (WB), black tea bread (BT),
β-glucan bread (βG), β-glucan plus black tea bread (βGBT). Each bread was incubated in an in vitro
system mimicking human digestion and colonic fermentation. Digestion with α-amylase significantly
(p = 0.0001) increased total polyphenol and polyphenolic metabolites from BT bread compared
with WB, βG, and βGBT. Total polyphenols in βGBT remained higher (p = 0.016; 1.3-fold) after
digestion with pepsin and pancreatin compared with WB. Fermentations containing βG and βGBT
produced similar propionate concentrations ranging from 17.5 to 18.6 mmol/L and total SCFA from
46.0 to 48.9 mmol/L compared with control WB (14.0 and 37.4 mmol/L, respectively). This study
suggests that combination of black tea with β-glucan in this functional bread did not impact on SCFA
production. A higher dose of black tea and β-glucan or in combination with other fibers may be
needed to increase SCFA production.
Keywords: gut microbiota; beta glucan; black tea; phenolic acids; short chain fatty acids; acetate;
propionate; butyrate; in vitro fermentation; in vitro digestion
1. Introduction
The gut microbiota is sustained by non-digested or non-absorbed food components. Two of the
key food constituents metabolized by the colonic bacteria are dietary fiber and plant polyphenols.
Some starch also escapes digestion and is available for fermentation in the colon. Starch digestion
could be influenced by the food matrix including dietary fiber. It is important to understand the impact
of combining food ingredients in functional foods on the supply of nutrients to the colonic microbiota
and the subsequent production of bioactive molecules including short chain fatty acids (SCFA) and
phenolic acids (PA).
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Starch and gluten are key components in bread that undergo physicochemical changes during the
bread making process [1]. Bread is commonly consumed in Western countries and can be manipulated
for further development of functional properties [2]. The addition of soluble fiber such as guar gum
(galactomannan) to bread reduced in vitro starch hydrolysis (approximately 31% against control wheat
bread) by preventing starch-α-amylase interactions [3]. Our previous findings demonstrated that
incorporating β-glucan into bread could help ‘preserve’ the starch granules compared with normal
wheat bread [4]. The presence of β-glucan conserved the starch structure and/or reduced the surface
area for α-amylase-starch interaction. These contributed to reduced starch hydrolysis which could
increase delivery of substrate to the colon for the gut microbiota.
β-Glucan is a soluble dietary fiber with mixed β-(1→3) and β-(1→4) glucosidic linkages.
Four gram of β-glucan per 30 g available carbohydrate has been approved by the European Food
Safety Authority (EFSA) to reduce the glycemic response without disproportionally increasing the
postprandial insulinemic response [5]. Studies have shown that puddings and snack bars prepared with
β-glucan positively reduced post-prandial glycemic (17% versus control) and insulin concentrations
(27% versus control) [6,7]. Mechanistically, low and high molecular weight β-glucan are fermented
by the intestinal microbiota, resulting in production of the short chain fatty acids (SCFA) acetate,
propionate, and butyrate [8]. Propionate acts as a precursor in hepatic glucose production and is
involved in appetite regulation through the stimulation of hepatic nerves [9]. The consumption of
inulin propionate ester (10 g/day) in healthy humans increased fullness by 14%, when compared
with an inulin control [10]. However, the dose (10 g/day) used in this study was very high and
is not attainable from normal dietary intake. The question remains on how to increase the level of
propionate in our body or whether the presence of another bioactive component such as polyphenols
can synergistically increase the health benefit of β-glucan.
Polyphenols found in foods such as fruits, vegetables, tea, and coffee are important bioactive
compounds associated with beneficial health effects such as reduction in blood pressure [11],
cardiovascular risk factors [12], and type 2 diabetes [13]. Polyphenols in fruits, vegetables, or cereals
are usually located in the plant cell walls or bound within the food matrix which reduces their
bioavailability [14]. However, polyphenols in beverages such as black tea are more ‘readily’ available
and can be used in formulations together with β-glucan. Black tea is an ideal choice for testing
synergistic effects of fiber and polyphenols because of its wide consumption. The average black
tea consumption in Europe is four cups/day (1000 mL) in males and three cups/day (865 mL) in
females [15]. Acute black tea intake (250 mL) containing 350 mg total polyphenols reduced postprandial
glycaemia by 52% in a randomized-crossover human intervention [8]. An in vivo animal study
suggested that black tea (5 mg/kg body weight) reduced glucose levels when compared with a
drug (acarbose) commonly used for type 2 diabetes mellitus treatment (T2DM) [16]. Mechanistically,
the presence of bioactive polyphenols inhibited α-amylase and/or α-glucosidase enzymic activity and
therefore the glycemic response blunts [17].
The health benefits of black tea are due to the presence of small and large molecular weight
polyphenols [9]. Black tea is rich in quercetin (10–25 mg/L), kaempferol (7–17 mg/L), and myricetin
(2–5 mg/L) and high molecular weights theaflavins (TF) and thearubigins (TR) [18,19]. TF and TR are
responsible for the pigments of black tea, derived by enzymatic oxidation during tea fermentation [19].
These large complexes are poorly digested and most tea polyphenols escape to the colon where they
are metabolized by the gut bacteria. In humans, tea flavan-3-ols reached the colon (50–70% of ingested
dose) after drinking a cup (300 to 500 mL) of green tea [20–22]. The polyphenols may be further
metabolized into SCFA by the gut microbiota. Unno and Osakabe demonstrated that 10 g/kg black tea
extract increased caecal propionate production in rats compared with green tea and the control [19].
Food components (e.g., fiber, polyphenols) can interact in several ways when eaten as a separate
meal, but if combined in the same food matrix in foodstuffs such as bread that are heavily transformed
during food processing, these interactions may be more complex. Tea polyphenols can interrupt
amylose recrystallisation that results in a more rigid structure more resistant to enzymatic action [23].
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Soluble β-glucan addition to a polyphenol containing food matrix has the potential to ‘trap’ high
molecular weight black tea polyphenols within the starch granules to form a complex and substrate for
colonic bacteria fermentation. We aimed to investigate the effects of combining black tea and β-glucan
in a food matrix on polyphenol release and SCFA production in an in vitro model mimicking human
digestion and fermentation.
2. Materials and Methods
2.1. Study Design
This was an in vitro study using two experimental approaches: (1) digestion of breads using a
model mimicking human gastric and duodenal phases of digestion to measure antioxidant potential
and (2) batch culture fermentations of predigested breads using fecal samples collected from healthy
donors (Figure 1).
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from WM Morrisons Supermarkets PLC (Bradford, UK). β-Glucan concentrate (from barley) 
(GlucagelTM) was purchased form DKSH (Quai du Rhône, France) and freeze dried black tea from 
Tata Global Beverages GB LTD (Greenford, UK). The black tea contained 452.2 (18.9) mg gallic acid 
equivalents/100 mL. 
2.2.2. Bread Preparation 
Breads were prepared using our previous recipe [4]. One portion of black tea (BT) bread (111 g) 
and β-glucan plus black tea (βGBT) bread (153 g) provided 30% of polyphenols that could be obtained 
from a cup (250 Ml) of black tea [24,25]. All ingredients (Table 1) were weighed and transferred into 
a baking pan. Bread was baked using a domestic bread maker (Morphy Richards Ltd., South 
Yorkshire, UK) set as follows: kneading (10 min), rising (20 min), kneading (15 min), rising (40 min), 
and baking (65 min), for a total baking time of 2 h 30 min. More water was added to β-glucan breads 
to compensate for additional water uptake by β-glucan [26]. 
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2.2. Bread Development
2.2.1. Materials
White wheat flour, yeast for baking, unsalted butter, and dried skimmed milk were purchased
from WM Morrisons Supermarkets PLC (Bradford, UK). β-Glucan concentrate (from barley)
(GlucagelTM) was purchased form DKSH (Quai du Rhône, France) and freeze dried black tea from
Tata Global Beverages GB LTD (Greenford, UK). The black tea contained 452.2 (18.9) mg gallic acid
equivalents/100 mL.
2.2.2. Bread Preparation
Breads were prepared using our previous recipe [4]. One portion of black tea (BT) bread (111 g)
and β-glucan plus black tea (βGBT) bread (153 g) provided 30% of polyphenols that could be obtained
from a cup (250 Ml) of black tea [24,25]. All ingredients (Table 1) were weighed and transferred into a
baking pan. Bread was baked using a domestic bread maker (Morphy Richards Ltd., South Yorkshire,
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UK) set as follows: kneading (10 min), rising (20 min), kneading (15 min), rising (40 min), and baking
(65 min), for a total baking time of 2 h 30 min. More water was added to β-glucan breads to compensate
for additional water uptake by β-glucan [26].
Table 1. Nutrient composition of experimental breads.
Ingredient (g) White Bread(WB)
Black Tea Bread
(BT)
β-Glucan Bread
(βG)
β-Glucan + Black
Tea Bread (βGBT)
Strong white wheat flour 500.0 500.0 500.0 500.0
NaCl 8.0 8.0 8.0 8.0
Sugar 6.0 6.0 6.0 6.0
Dehydrated yeast 8.0 8.0 10.0 10.0
Butter (unsalted) 6.0 6.0 6.0 6.0
Skimmed milk powder 7.0 7.0 7.0 7.0
β-glucan 0.0 0.0 35.0 35.0
Black tea 0.0 2.5 0.0 2.5
Water (Ml) 300 300 540 540
Total 835.0 837.5 1112.0 1114.5
2.3. In Vitro Digestion Model
The in vitro digestion models mimicked the human gastro intestinal (GI) tract as described in
detail by Aura et al. [27]. The aim of this procedure was to remove digestible starch, protein, and fat.
Following digestion, retentates were freeze-dried and used for antioxidant potential measurements
and as substrates for in vitro batch fermentation. Briefly the procedure was as follows:
(i) Oral phase: Bread samples containing 50 mg available carbohydrate were incubated with
α-amylase (50 U/sample) (Sigma-Aldrich, Dorset, UK) at 37 ◦C for 5 min (mimicking oral
chewing).
(ii) Gastric phase: The pH of the mixture was adjusted to 2.5 using HCL (0.15 M, pH 2.5) and incubated
with pepsin (0.7 mL, 2 mg/mL in 0.02 M HCl) at 37 ◦C for 2 h in a shaking water bath.
(iii) Small intestine (duodenum and ileum) phase: The pH was adjusted to 7.0 using sodium hydroxide
(6 M). A porcine extract bile acid (Sigma B8631) (2.7 mL, 150 ng/mL in 0.15 M sodium bicarbonate)
and pancreatin (mixture of amylase, proteases and lipase, 2.7 mL, 75 mg/mL in 0.15 M sodium
bicarbonate) (Sigma-Aldrich, Dorset, UK) were added and incubated at 37 ◦C for 4 h on a shaking
water bath. Absorption in the small intestine was simulated after digestion using dialysis tubing
(molecular weight 500–1000 Dalton cut-off, 35 cm long with flat width of 31 mm and diameter of
20 mm) (Spectrum Laboratories, Rancho Dominguez, CA, USA) for 6 h in 2 L distilled water.
(iv) The non-digested/dialyzed products (retentate) were carefully removed from the dialysis
tube and freeze-dried. The freeze-dried sample was used as substrate in the in vitro
fermentation model.
2.4. Determination of Total Polyphenols
Total polyphenol (crude) released from breads after the in vitro digestion was estimated using the
method described by Slinkard and Singleton [28]. In short, freeze-dried dialyzed samples (20 µL) were
mixed with distilled water and diluted using Folin-Ciocalteu reagent. The mixture was left for 5 min
at room temperature and 70 µL of 6% (w/v) Na2CO3 was added and left for a further 90 min at room
temperature before reading the absorbance at 765 nm with a spectrophotometer (Multiskan® Spectrum,
Thermo Labsystems, Vantaa, Finland). Gallic acid in the range of 50–1000 µg/mL was used as the
standard. Gallic acid equivalents (GAE, µg/g retentate) were used to report total polyphenol content.
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2.5. Antioxidant Potential in Retentates—Ferric Reducing Ability of Plasma (FRAP) Assay
The assay was conducted on the freeze-dried dialyzed samples from the in vitro digestion
as described by Benzie and Strain [29]. The FRAP reagent was prepared by mixing 10 mM 2, 4,
6-Tri(2-pyridyl)-s-triazine (TPTZ) in 40 mM HCl, 20 mM FeCl3 and 0.3 M acetate buffer (pH 3.6)
in a 1:1:10 ratio, this was warmed and read for absorbance at time 0 using a spectrophotometer
(Multiskan® Spectrum, Thermo Labsystems, Vantaa, Finland). Samples (100 µL) were added to 1.8 mL
of FRAP reagent and 100 µL of deionized water followed by a 4 min incubation at 37 ◦C. The final
absorbance was read at 593 nm and subtracted from the initial absorbance to report total FRAP value
(µg Fe2+ equivalents/g retentate).
2.6. In Vitro Batch Fermentation
In vitro batch fermentation mimic colonic activity and was performed using a standardized
method described by Jaganath et al. [30]. This measured the fermentability of starch and the
polyphenols-β-glucan complex from breads after digestion. Fecal samples obtained from four healthy
Caucasian individuals (mean age, 26; SD 4 years) who had not taken any antibiotics in the past six
months and had no gastrointestinal problem. The fecal samples were used for batch fermentation
within 2 h of passage. The College of Medical, Veterinary and Life Sciences Ethics Committee,
University of Glasgow approved the study protocol (Application No.: 2011023). Signed informed
consent was obtained from all individuals prior to sampling.
In summary, the in vitro batch fermentation used a medium of tryptone, macro and microminerals
in a buffer with a redox indicator at pH 7.0. [30]. All glassware and sampling apparatus were sterilized
before use. The fermentation medium was boiled to degas the solution and then cooled to 37 ◦C in
oxygen free nitrogen (OFN). This was mixed with fecal slurry prepared from fresh feces homogenized
in phosphate buffer 32% (w/v). The slurry (5 mL) was mixed with fermentation medium (42 mL) and
reducing solution (2 mL) in a sterilized McCartney bottle. The bottles were sealed and again purged
with OFN for 1 min and placed in a shaking water bath at 37◦C to mimic conditions in the colon.
Aliquots of fermentation solution (3 mL) were taken from the fermentation vessels through self-sealing
lids with sterile syringes and needles at 0, 6, and 24 h for the measurement of pH and SCFA (acetate,
propionate, and butyrate). The pH was not strictly controlled throughout the procedure but allowed to
drop in a similar manner to the pH in the proximal colon where low pH is compensated by absorption
of SCFA and secretion of bicarbonate. The pH range we recorded has been detected in the proximal
colon during active fermentation in humans and in pigs [31,32].
SCFA were estimated by an established method [33]. A mixture of internal standard (100 µL;
3-methyl-n-valeric acid) and 100 µL orthophosphoric acid was added to the fermentation fluid
(800 µL) and. The mixture was mixed rigorously followed by extraction with 3 mL of diethyl ether.
The upper phase was collected and pooled in 15 mL tubes. The extractions were then analyzed by
gas chromatography with a flame ionization detector (GC-FID) (Thermo Quest Ltd., Manchester, UK)
equipped with a Zebron ZB-Wax capillary column (15 m × 0.53 mm id) (Phenomenex, Cheshire, UK).
Data were analyzed by Chrom-Card software (Thermo Quest, Milan, Italy). Individual SCFA were
identified by comparing retention times with authentic standards (acetic acid, propionic acid, isobutyric
acid, n-butyric acid, isovaleric acid, n-valeric acid, n-hexanoic acid, heptanoic acid, and n-octanoic acid).
2.7. Statistical Analysis
SPSS software (SPSS version 22.0, SPSS Inc., Chicago, IL, USA) was used for data analysis.
Normality was determined using Shapiro Wilk test. Data are expressed as mean ± standard deviation,
SD). One-way ANOVA with Bonferroni correction assessed the mean differences between groups
(log transformed data). Repeated measures ANOVA tested differences between 0, 6, and 24 h. Statistical
significance was accepted at p < 0.05.
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3. Results
3.1. Total Polyphenols and Antioxidant Potential
The release of polyphenols (crude) following in vitro digestion is shown in Table 2.
Total polyphenol content of black tea bread (BT) was higher (1.6-fold, p = 0.0001) with 361.1 ± 20.0 µg
GAE/g retentate compared with white bread (WB) (222.6 ± 63.0 µg GAE/g retentate). The release
of polyphenols after digestion with α-amylase at 0 h ranged from 222.6 ± 63.0 to 361.1 ± 40.0 µg
GAE/g retentate. Following gastric digestions with pepsin and pancreatin and 6 h dialysis in retentates
resulted in an increase in polyphenol content of βGBT (1.3-fold) (p = 0.016) compared with WB.
Table 2. Total polyphenol (crude) content and antioxidant potential (FRAP assay) of retentates of
breads prepared with black tea and β-glucan.
Bread
Total Polyphenols
(µg GAE/g Retentate)
FRAP Activity of Retentate
(µg Fe2+ Equivalents/g Retentate)
* Pre-Digested ** Digested * Pre-Digested ** Digested
WB 222.6 ± 63.0 ade 1077.7 ± 250.2 ab 338.9 ± 131.2 ab 3633.3 ± 645.0 a
BT 361.1 ± 40.0 bc 1228.9 ± 106.0 ac 1056.2 ± 131.4 c 4024.5 ± 198.8 a
βG 229.1 ± 0.0 d 1298.3 ± 276.0 ac 236.2 ± 80.4 b 3351.9 ± 552.2 a
βGBT 291.5 ± 0.0 e 1379.9 ± 146.8 c 608.0 ± 119.0 d 3998.8 ± 1030.4 a
Asterisk (*) indicates predigested bread sample with α-amylase (0 h). Double asterisk (**) indicates digested bread
sample with pepsin (2 h), pancreatin (5 h), and followed by dialysis for 6 h. Values with different letters (a, b, c, d, e)
were significantly (p < 0.05) different between breads.
The results of the FRAP assay in retentates is shown in (Table 2). Black tea bread (BT) had the
highest antioxidant (3.1-fold, p = 0.0001) activity when compared with WB. Similarly, after digestion
with α-amylase both breads containing BT showed higher antioxidant activity compared to βG
(p = 0.0001). The antioxidant potential did not change significantly after gastric digestions for all breads.
3.2. Short Chain Fatty Acid Production
3.2.1. Fermentation pH
There was no significant difference in pH between the breads at baseline, 6, and 24 h (Table 3).
The pH was significantly (p = 0.001) lower at 6 h for all breads compared with 0 h in the range
of 5.0 ± 0.8 to 5.5 ± 0.2. The pH remained significantly (p < 0.05) lower at 24 h after fermentation
compared with baseline in the range of 5.2 ± 1.0 to 5.8 ± 0.4.
Table 3. Fermentation pH at 0, 6, and 24 h (mean + SD).
Bread 0 h 6 h 24 h
WB 6.6 ± 0.2 5.5 ± 0.2 5.8 ± 0.4
BT 6.6 ± 0.4 5.4 ± 0.4 5.7 ± 0.8
βG 6.6 ± 0.4 5.1 ± 0.8 5.3 ± 1.0
βGBT 6.6 ± 0.4 5.0 ± 0.8 5.2 ± 1.0
There were significant (p < 0.05) time interactions between 0 h vs. 6 h and 0 h vs. 24 h.
3.2.2. Effects of Adding β-Glucan in Bread on SCFA Production
SCFA production in breads containing β-glucan is shown in Figure 2. There was little impact of
adding β-glucan in breads on individual SCFA compared with control WB. There were no significant
differences in the production of acetate and propionate for BT, βG, and βGBT compared with control
WB. The total ratio of individual SCFA (the sum of acetate, propionate and butyrate) of WB, BT, βG,
and βGBT was comparable with 54:38:8, 55:37:8, 55:38:7, and 56:38:6, respectively.
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Figure 2. Production of SCFA (mmol/L) after 24 h fermentation of different breads after in vitro digestion. Results are mean (SD) (n = 4 donors). WB, white bread; 
BT, black tea bread; βG, β-glucan bread; βGBT, β-glucan with black tea bread. 
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Figu e 2. Production of SCFA ( m l/L) after 24 h fermentati of differ t breads after in vitro
digestion. Results are mean (SD) (n = 4 donors). WB, white bread; BT, black tea bread; βG, β-glucan
bread; βGBT, β-glucan with black tea bread.
3.2.3. Donor SCFA Variability
There was significant individual variability in SCFA production among donor samples (Figure 3).
Donors 3 and 1 were consistently highest and lowest acetate producers, respectively, for all breads
(Table 4). Donors 1 and 2 were consistently higher propionate producers for all breads compared
with donor number 3. Donor number 1 was a higher butyrate producer compared with donor
number 2 and 3.
Table 4. Individual SCFA ranking by donor at end of fermentation of different breads after in vitro
digestion (24 h).
Bread
Individual SCFA by donor
Acetate Propionate Butyrate Total
Donor 1 BT = βGBT > WB > βG BT > WB > βGBT > βG βGBT = βG > WB > BT BT > WB > βGBT > βG
Donor 2 βGBT > βG > BT > WB βGBT > βG > BT > WB βG > βGBT > BT > WB βGBT > βG > BT > WB
Donor 3 βGBT > βG > BT > WB βG > βGBT > BT > WB BT > WB > βG > βGBT βGBT > βG > BT > WB
Donor 4 βGBT > βG > WB > BT βGBT > βG > BT > WB βGBT > βG > BT > WB βGBT > βG > BT > WB
WB, white bread; BT, black tea bread; βG, beta glucan bread; βGBT, beta glucan with black tea bread.
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4. Discussion
In this study, we investigated the effect of combining β-glucan and black tea in a food matrix
(bread) to determine if there was a synergistic impact on total polyphenol and SCFA production
by gut microbiota in an in vitro model of digestion and fermentation mimicking the human large
intestine. In vitro digestion of BT bread with α-amylase increased polyphenol content and antioxidant
potential compared with WB and βGBT breads. Tea polyphenols and high amylose maize starch
form polyphenols-amylose complexes following thermal treatment [23]. The tea polyphenol-amylose
complex modified the normal amylose retrogradation (re-crystalline) to a low-ordered crystalline
structure. In another study, the addition of tea polyphenols (16%, w/w basis) prevented starch
retrogradation [34]. Amylose and tea polyphenols are rich in hydroxyl groups, these hydrogen bonds
govern the interaction between starch and tea polyphenols during gelatinization [34]. However, in our
study, black tea was added to the bread mix. This will have different food matrix effects due to
mixing, proofing, and baking. In previous studies, the addition of polyphenol extracts and pectin
influenced the cross-linking of gluten leading to more water retention and changes in texture (softer
bread) [35,36]. Therefore we hypothesized that adding black tea polyphenols to the bread mix will
interact with gluten forming cross-links and a softer bread, which could expose starch granules to
α-amylase activity and increased antioxidant potential of BT bread. On the other hand, in βGBT
bread system, the interaction is much more complex than BT because of a food-matrix interaction
between gluten, β-glucan, and black tea polyphenols. Simonsen et al. showed that tea polyphenols
had the ability to form complexes with soluble β-glucan through hydrogen bonding [37]. This was
further confirmed in an in vitro model system where the adsorption capacity of epigallocatechin
gallate (EGCG), a major tea polyphenol, in the presence of β-glucan was clearly governed by hydrogen
bonding [38,39]. According to this we expect that black tea polyphenols could form complexes with
the gluten-network while β-glucan ‘preserves’ the starch structure for digestion by α-amylase. In our
experiment, total polyphenols and antioxidant activity of βGBT remained higher compared with WB
in an in vitro model mimicking small intestine enzymic digestion and absorption. The presence of
polyphenols is of interest as they may be further metabolized by the colonic microbiota to phenolic
acids [40]. However, a limitation of our study is the use of a simple in vitro total polyphenol method
suitable for estimation of ‘crude’ polyphenols [41]. A more detailed analysis of phenolic acids using
LC-MS would have provided a more comprehensive polyphenol profile.
In a human study where ileostomists ingested 452 µmol flavan-3-ols (from tea), it was shown
that a large proportion (up to 73%) of flavan-3-ols pass from the small intestine to the colon [40].
Tea polyphenols are metabolized by colonic bacteria in the colon into SCFA and phenolic acids before
being further metabolized in the liver or excreted [40]. The human gut microbiota metabolized
tea polyphenols to 3-(3′-hydroxyphenyl)propionic and 3-(4′-hydroxyphenyl)propionic acids [42,43].
Liu et al. showed that gut microbiota degraded epigallocatechin gallate and epicatechin gallate and
subsequently reduced their bioavailability [44]. However, the bioactivity of these phenolics acids in
human health remains unknown and needs further investigation. Unno and Osakabe demonstrated
that black tea supplementation in rats significantly reduced the relative abundance of Clostridium
subcluster XIVa and Clostridium cluster XI compared with control [19]. Another study demonstrated
that methylated (−)-epigallocatechin-3-O-(3-O-methyl) gallate (main component of tea polyphenols)
reduced the Firmicutes/Bacteroidetes ratio in an experimental rat [45]. Still, it is still unknown whether
the (polyphenol-linked β-glucan will be undigested and enter the large intestine to be metabolized by
the bacteria to SCFA. To answer this question, the fermentability of the breads was investigated using
an in vitro human colonic fermentation model.
This study showed that acetate and propionate were similar in the fermentation medium
containing βG and βGBT compared to WB. Propionate production with βG was 17.5 mM and
for βGBT 18.6 mM, with an acetate:propionate:butyrate production ratio of 56:38:6. This was
similar to other in vitro studies of β-glucan either from oat or barley [6,46,47]. The propionate was
in the range of 5.5–18 mM (acetate:propionate:butyrate ratio 51:32:17) considered propionate-rich.
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A previous study showed 2-fold individual differences in SCFA production [48]. In our study,
donor number 3 consistently showed higher acetate and lower propionate production compared
with donors number 1 and 2. This was similar to Harris et al., 2017 [49] who reported inter-individual
variations in SCFA (acetate, propionate, and butyrate) with a range of 20 mmol/L to 100 mmol/L from
15 healthy Caucasians.
We have studied the fermentation of the predigested breads in an in vitro batch culture model,
which is well established [30] but has several limitations common to all batch cultures. The products of
fermentation are not removed and pH was not controlled, although the pH values reached in our study
are representative of those found in the colon after ingestion of fermentable carbohydrates [31,32].
Continuous culture models, including a three-stage system representing proximal and distal colon
environments [50] may be a better match to the human colon but these are expensive and impractical
to use for multiple comparisons of food components. Indeed, most methods currently used have
limitations in relation to host functionality [51].
An early study by Cummings et al. showed that dietary supplementation does not increase
colonic production or circulating level of propionate due to variability in gut microbial activity [52].
Another study showed that an in vitro batch fermentation of inulin-propionate ester increased the
microbial activity of Bifidobacterium spp, Bacteroides/Prevotella and Atopobium cluster compared with
baseline (0 h) but did not differ significantly compared with the control (no substrate) and inulin-only
control [53]. Inulin-propionate ester stimulated the release of appetite hormones (GLP-1 and PYY)
and subsequently reduced energy intake among obese subjects [53]. However, the dose used was
much higher than that produced in in vitro studies [46,47]. Propionate may activate G protein-coupled
receptor 41, on colonic enteroendocrine L-cells [54,55] which are responsible for secretion of GLP-1
and PYY and may suppress food intake [54–57]. However, we failed to observe any synergistic effects
of adding β-glucan in bread on SCFA production. This lack of effect could be partly explained by the
context of the added β-glucan. β-glucan was not shown to increase product viscosity when added
to solid food such as bread and biscuits unlike when added to liquid product [58]. Verbeke et al.
using stable isotopes in vivo reported that less propionate was produced from barley kernel than with
barley porridge (viscous liquid) [59]. This might be due to the lower water holding capacity of the
barley kernel.
5. Conclusions
As expected, this study showed that BT bread had higher antioxidant activity and polyphenol
content when digested with α-amylase compared with WB and βG. Antioxidant and polyphenol
content of βGBT bread remained higher after in vitro small intestine digestion. β-glucan breads
showed higher propionate concentrations at 24 h compared with baseline (0 h) but did not change
significantly between breads. Black tea addition with β-glucan had no impact on SCFA production
when added in bread. A higher dose of tea and β-glucan or combination with other soluble dietary
fibers may be required to impact SCFA production.
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